Skip to main content
. 2020 Dec 2;49(D1):D1207–D1217. doi: 10.1093/nar/gkaa1043

Figure 5.

Figure 5.

One major goal of KPMP is to refine classification of kidney diseases in molecular, cellular, and phenotypic terms and thereby identify novel targeted therapies. The kidney-related HPO terms are being used in multiple ways in KPMP. For example, KPMP has used the HPO terms for clinical and pathological phenotype annotations, integrative Kidney Tissue Atlas Ontology (KTAO) (39) development, and systematic data integration software development.